Gene therapy stocks slammed after scientist reveals safety concerns … – MarketWatch
MarketWatch |
Gene therapy stocks slammed after scientist reveals safety concerns …
MarketWatch Shares of gene therapy companies fell sharply Tuesday, after a report by a prominent scientist revealed the safety concerns that led him to resign recently from Solid Biosciences Inc.'s scientific advisory board. New study shows severe toxicity with high-dose AAV9-based gene therapy in animal models Gene therapy pioneer James Wilson sounds an alarm on high-dose … Gene Therapy May Not Be a Viable Option for Many Patients | GEN |
